LENNOX GASTAUT SYNDROME
Clinical trials for LENNOX GASTAUT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Extended safety check for promising seizure drug shows promise
Disease control CompletedThis study followed 412 patients with rare, severe seizure disorders like Dravet and Lennox-Gastaut syndromes to check the long-term safety of an add-on medication called ZX008 (fenfluramine). Participants had already taken the drug in earlier studies and continued it here to mon…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
Year-Long epilepsy drug trial tests safety in devastating childhood conditions
Disease control CompletedThis study tested the long-term safety of an experimental epilepsy drug called LP352 in people with severe, difficult-to-treat epilepsy syndromes like Dravet and Lennox-Gastaut. It followed 41 participants for up to 52 weeks to monitor side effects and see how well the drug conti…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC